Henri Bayle

Henri Bayle has a diverse work experience in the pharmaceutical and medical field. Henri is currently the Chief Technology Officer and Chief Development Officer at NKILT Therapeutics since July 2021. Prior to that, they worked at Bellicum Pharmaceuticals, Inc. where they held various roles including Vice President of Research, Senior Director, and Director from November 2014 to March 2023. Before joining Bellicum Pharmaceuticals, Inc., Henri worked at Baylor College of Medicine as an Assistant Professor from 2007 to 2014. Henri also worked at Stanford University School of Medicine as a Research Scientist from 2001 to 2006.

Henri Bayle has a Bachelor of Science (B.Sc.) degree in Genetics from the University of Alberta. Later, they pursued a Doctor of Philosophy (Ph.D.) in Molecular Biology at Princeton University. Currently, Henri is a Postdoctoral Fellow at the Stanford University School of Medicine, specializing in the field of Pathology.